Organization
SynCore Biotechnology
4 clinical trials
Clinical trial
An Open-label, Randomized, Controlled Phase III Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast CancerStatus: , Estimated PCD: 2025-03-01
Clinical trial
An Open-Label, Phase II Study to Evaluate SCB01A in Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer Who Have Received Platinum-Based TreatmentStatus: Terminated, Estimated PCD: 2017-12-01
Clinical trial
An Open-Label, Phase II Study to Evaluate the Efficacy and Safety of SCB01A in Subjects With Recurrent or Metastatic Squamous Cell Head and Neck Cancer Who Have Failed Platinum-Based TreatmentStatus: Terminated, Estimated PCD: 2018-11-20